SDC1 and metastatic malignant neoplasm in the lymph nodes: Peretti et al.24 did not find any association between syndecan-1 immunoexpression and any of the clinicopathological data, including tumor grade, lymphovascular space invasion, lymph node metastasis, and tumor stage.